Profile
Karl Anders Axel Swartling is currently the Chief Executive Officer at Stena Sessan AB and a Director at Affibody AB. He previously held positions as a Director at Aerocrine AB from 2004 to 2011, a Director at Cellectricon AB, and the Managing Director at Sjätte AP-fonden from 2012 to 2019.
He also served as the Managing Director at Investor Growth Capital AB from 2004 to 2012.
Additionally, he has held various director positions at Newron Sweden AB, Mando AB, Global Health Partner Ltd., Tobii AB, Atlas Antibodies AB, Cambio Healthcare Systems AB, GHP Specialty Care AB, PocketMobile Communications AB, Sörman Intressenter AB, and KTH Holding AB. He started his career as a Principal at Mckinsey & Co., Inc. (Munich).
Mr. Swartling obtained an MBA from Stockholm School of Economics in 1989.
Karl Anders Axel Swartling active positions
| Companies | Position | Start |
|---|---|---|
Affibody AB
Affibody AB BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops radioligand therapies for cancer treatment | Director/Board Member | - |
Former positions of Karl Anders Axel Swartling
| Companies | Position | End |
|---|---|---|
Sjätte AP-fonden (Private Equity)
Sjätte AP-fonden (Private Equity) Investment ManagersFinance AP6 invests in small and mid market companies located in Sweden. The firm targets companies operating across a broad range of sectors. It provides financing for buyout and fund investments. It also makes co-investments. | Chief Executive Officer | 2019-02-28 |
Sjätte AP-fonden
Sjätte AP-fonden Investment ManagersFinance AP6 is an active, growth-oriented manager which follows a bottom-up fundamental investment approach. They use their own analysis tools and databases whenever they conduct a fund assessment. The firm has different teams for each sector and geographic area when they make their analysis. They invest directly in Swedish small- and medium-sized unlisted companies, either as sole investor or jointly with business partners. To assess the sustainability efforts of the funds, AP6 uses their own scorecard which has three categories. | Chief Executive Officer | 2019-02-28 |
Investor Growth Capital AB
Investor Growth Capital AB Investment ManagersFinance IGC is a long-term investor with a top-down investment approach. They describe their investment attitude as patient and flexible. They are active investment partners seeking management teams operating in markets displaying sustainable growth characteristics. IGC commits themselves to board representation working closely for strategic decisions, financial and human resource allocations, potential acquisitions analyses and sources of additional capital. Their investee firms gain access to IGC's worldwide network of industry experts, advisors, and local knowledge over several geographic markets. IGC Europe invests primarily in expansion-stage firms in the technology and life sciences sectors in Northern Europe. They have an investment horizon from three to seven years. They typically invest between USD $3 million and $30 million. They acquire minority interest. IGC Asia targets expansion-stage firms in IT, software, semiconductors and Internet/media within Asia. Their investments range from USD $8 to $15 million over an investment period of three to six years. IGC US concentrates on investments in unlisted firms in healthcare and either listed or unlisted firms in IT sectors in North America. Generally, they invest in healthcare firms that have approved or marketed products. IT investments will typically be beyond the concept stage. | President | 2012-01-20 |
| AEROCRINE AB | Director/Board Member | 2011-11-15 |
Mckinsey & Co., Inc. (Munich) | Corporate Officer/Principal | - |
Training of Karl Anders Axel Swartling
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 18 |
|---|---|
Aerocrine AB
Aerocrine AB Electronic Equipment/InstrumentsElectronic Technology Manufactures and distributes medical devices for asthma patients | Electronic Technology |
Cellectricon AB
Cellectricon AB Miscellaneous Commercial ServicesCommercial Services Provides cell-based screening services to accelerate drug discovery | Commercial Services |
Affibody AB
Affibody AB BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops radioligand therapies for cancer treatment | Health Technology |
Sjätte AP-fonden
Sjätte AP-fonden Investment ManagersFinance AP6 is an active, growth-oriented manager which follows a bottom-up fundamental investment approach. They use their own analysis tools and databases whenever they conduct a fund assessment. The firm has different teams for each sector and geographic area when they make their analysis. They invest directly in Swedish small- and medium-sized unlisted companies, either as sole investor or jointly with business partners. To assess the sustainability efforts of the funds, AP6 uses their own scorecard which has three categories. | Finance |
Investor Growth Capital AB
Investor Growth Capital AB Investment ManagersFinance IGC is a long-term investor with a top-down investment approach. They describe their investment attitude as patient and flexible. They are active investment partners seeking management teams operating in markets displaying sustainable growth characteristics. IGC commits themselves to board representation working closely for strategic decisions, financial and human resource allocations, potential acquisitions analyses and sources of additional capital. Their investee firms gain access to IGC's worldwide network of industry experts, advisors, and local knowledge over several geographic markets. IGC Europe invests primarily in expansion-stage firms in the technology and life sciences sectors in Northern Europe. They have an investment horizon from three to seven years. They typically invest between USD $3 million and $30 million. They acquire minority interest. IGC Asia targets expansion-stage firms in IT, software, semiconductors and Internet/media within Asia. Their investments range from USD $8 to $15 million over an investment period of three to six years. IGC US concentrates on investments in unlisted firms in healthcare and either listed or unlisted firms in IT sectors in North America. Generally, they invest in healthcare firms that have approved or marketed products. IT investments will typically be beyond the concept stage. | Finance |
Stockholm School of Economics
Stockholm School of Economics Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Newron Sweden AB
Newron Sweden AB Pharmaceuticals: MajorHealth Technology Develops and manufactures therapeutic drugs for central nervous system disorders | Health Technology |
Mando AB
Mando AB Medical/Nursing ServicesHealth Services Offers health care services | Health Services |
Global Health Partner Ltd.
Global Health Partner Ltd. Medical/Nursing ServicesHealth Services Provides health services | Health Services |
Tobii AB
Tobii AB Electronic Production EquipmentElectronic Technology Develops and delivers eye tracking solutions and components | Electronic Technology |
Atlas Antibodies AB
Atlas Antibodies AB BiotechnologyHealth Technology Develops, produces and markets reagents for biomedical research | Health Technology |
Cambio Healthcare Systems AB
Cambio Healthcare Systems AB Packaged SoftwareTechnology Services Develops medical record systems for healthcare sector | Technology Services |
Sjätte AP-fonden (Private Equity)
Sjätte AP-fonden (Private Equity) Investment ManagersFinance AP6 invests in small and mid market companies located in Sweden. The firm targets companies operating across a broad range of sectors. It provides financing for buyout and fund investments. It also makes co-investments. | Finance |
GHP Specialty Care AB
GHP Specialty Care AB Medical/Nursing ServicesHealth Services Provides healthcare services | Health Services |
PocketMobile Communications AB
PocketMobile Communications AB Packaged SoftwareTechnology Services Develops mobile communication solutions and services | Technology Services |
Sörman Intressenter AB
Sörman Intressenter AB Miscellaneous Commercial ServicesCommercial Services Provides technical solutions | Commercial Services |
KTH Holding AB
KTH Holding AB Investment ManagersFinance KTH Holding invests in companies located in Sweden. The firm targets companies operating in a broad range of sectors and industries. It provides financing for seed and early stage capital requirements. | Finance |
Mckinsey & Co., Inc. (Munich) |
- Stock Market
- Insiders
- Karl Anders Axel Swartling
















